Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Continuous therapy response references for BCR::ABL1 in pediatric chronic myeloid leukemia (Volz C et al. Sci Rep, Oct 2023)

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
Volz C et al. Sci Rep, October 2023 – open access publication

 

 

 

Somatic variant profiling in chronic phase pediatric CML (Behrens YL et al. Haematologica, Sept 2023)

Somatic variant profiling in chronic phase pediatric CML
Behrens YL et al. Haematologica, Sept 2023 (epub ahead of print) – open access publication

 

 

 

Priapism at diagnosis of pediatric chronic myeloid leukemia: Data derived from a large cohort of children and teenagers and a narrative review on priapism management (Suttorp M et al. J Clin Med

Priapism at Diagnosis of Pediatric Chronic Myeloid Leukemia: Data Derived from a Large Cohort of Children and Teenagers and a Narrative Review on Priapism Management
Suttorp M et al. J Clin Med, July 2023 - open access publication

 

 

 

The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study (Hijiya N et al. Blood Adv, Sept 2023)

The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
Hijiya N et al. Blood Adv, Sept 2023 (epub ahead of print)

 

 

 

Chronic myeloid leukemia in children and adolescents (Gotesman M et al. Adv Pediatr, Aug 2023)

Chronic myeloid leukemia in children and adolescents - Review
Gotesman M et al. Adv Pediatr, August 2023

 

 

 

  1. Effect of imatinib mesylate and growth in pediatric CML: A systematic review and meta-analysis (J Pediatr Hematol Oncol, July 2023)
  2. Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults (Mersin S et al. Expert Opin Pharmacother, July 2023)
  3. Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase CML in the tyrosine kinase inhibitor era (Ishida H et al. Am J Hematol, May 2023)
  4. Pediatric chronic myeloid leukemia in myeloid blast crisis (Dey B and Dutta A. Autpos Case Rep, April 2023)